Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation – a 4-week, randomized, double-blind, placebo-controlled, dose-response study - Goldberg, M; Li, Y P; Johanson, J F (Aliment Pharmacol Ther, 2010)
et al.